data_6ji7_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ji7 _Structure_validation_residue.Date_analyzed 2020-02-21 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.624 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.483 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.494 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.511 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' H ' HG21 ' A' ' 26' ' ' ILE . 48.8 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.479 ' HB2' ' N ' ' A' ' 20' ' ' CYS . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD21 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 24' ' ' ILE . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' OXT' HD21 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.742 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.742 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 HD12 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.4 ' OXT' HD12 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 HD12 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.582 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.747 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.747 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 24' ' ' ILE . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.621 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.507 ' H ' HG21 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.611 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.607 HD12 ' SG ' ' A' ' 23' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.965 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.965 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.573 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.553 ' O ' HD13 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 8' ' ' LEU . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.445 ' H ' HG13 ' A' ' 26' ' ' ILE . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.652 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD11 ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG1' ' H ' ' A' ' 27' ' ' TRP . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.404 ' H ' ' CG1' ' A' ' 26' ' ' ILE . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.512 0.196 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.49 52.69 0.45 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.659 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 -130.71 23.89 5.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.624 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.483 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.494 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.511 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' H ' HG21 ' A' ' 26' ' ' ILE . 48.8 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.15 85.07 0.11 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.382 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -142.7 88.46 2.06 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.479 ' HB2' ' N ' ' A' ' 20' ' ' CYS . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD21 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 24' ' ' ILE . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' OXT' HD21 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.34 -95.44 0.12 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -145.56 91.71 2.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.742 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.742 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.478 0.18 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.96 -86.53 1.9 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.402 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.08 89.65 2.19 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD12 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.4 ' OXT' HD12 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.558 0.218 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.61 57.93 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -150.28 95.73 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 HD12 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.582 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.747 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.747 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 24' ' ' ILE . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.539 0.209 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.19 110.33 3.07 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.536 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 -144.14 91.33 2.2 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.621 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.439 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.507 ' H ' HG21 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.533 0.206 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.06 88.92 0.12 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 28.96 8.09 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.611 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.38 89.88 0.11 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.561 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -134.63 82.55 1.97 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.607 HD12 ' SG ' ' A' ' 23' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.965 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.965 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.573 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.553 ' O ' HD13 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 8' ' ' LEU . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.509 0.195 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.24 95.64 0.68 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -144.7 91.63 2.19 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.445 ' H ' HG13 ' A' ' 26' ' ' ILE . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.652 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.52 0.2 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.41 104.21 2.56 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -148.84 94.36 2.25 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD11 ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG1' ' H ' ' A' ' 27' ' ' TRP . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.404 ' H ' ' CG1' ' A' ' 26' ' ' ILE . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' H ' HG11 ' A' ' 34' ' ' VAL . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.614 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.603 ' H ' HG22 ' A' ' 26' ' ' ILE . 56.1 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD23 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 28' ' ' GLN . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' H ' HG22 ' A' ' 26' ' ' ILE . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 11' ' ' PRO . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 8' ' ' LEU . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 35' ' ' GLY . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.652 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' OXT' HD23 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.767 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD13 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.401 ' OXT' HD13 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.517 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.766 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 35' ' ' GLY . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.615 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.543 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.562 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 33' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.99 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.99 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.568 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.661 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.512 0.196 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.49 52.69 0.45 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.659 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 -130.71 23.89 5.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.614 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.603 ' H ' HG22 ' A' ' 26' ' ' ILE . 56.1 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.15 85.07 0.11 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.382 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -142.7 88.46 2.06 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD23 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 28' ' ' GLN . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' H ' HG22 ' A' ' 26' ' ' ILE . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 11' ' ' PRO . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 8' ' ' LEU . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 35' ' ' GLY . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.652 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' OXT' HD23 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.34 -95.44 0.12 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -145.56 91.71 2.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.767 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.478 0.18 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.96 -86.53 1.9 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.402 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.08 89.65 2.19 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD13 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.401 ' OXT' HD13 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.558 0.218 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.61 57.93 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -150.28 95.73 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.517 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.766 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 35' ' ' GLY . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.539 0.209 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.19 110.33 3.07 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.536 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 -144.14 91.33 2.2 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.615 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.543 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.562 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.533 0.206 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.06 88.92 0.12 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 28.96 8.09 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.38 89.88 0.11 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.561 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -134.63 82.55 1.97 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 33' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.99 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.99 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.568 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.509 0.195 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.24 95.64 0.68 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -144.7 91.63 2.19 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.661 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.52 0.2 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.41 104.21 2.56 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -148.84 94.36 2.25 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.614 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.603 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.8 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD23 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 28' ' ' GLN . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' H ' HG22 ' A' ' 26' ' ' ILE . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 11' ' ' PRO . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 8' ' ' LEU . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 35' ' ' GLY . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.652 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' OXT' HD23 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.767 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD13 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.401 ' OXT' HD13 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.517 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.766 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 35' ' ' GLY . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.615 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.543 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.562 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 33' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.99 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.99 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.568 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.661 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.512 0.196 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.49 52.69 0.45 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.659 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 9.8 pt-20 -130.71 23.89 5.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.939 0.399 . . . . 0.0 111.47 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 4' ' ' GLU . 19.6 p 53.14 164.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.801 1.24 . . . . 0.0 113.58 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -141.17 157.94 65.49 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.362 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HB3' ' OXT' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -59.24 98.27 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 121.722 1.615 . . . . 0.0 109.656 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.09 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.145 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.57 -74.5 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.571 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 17' ' ' TRP . 2.5 mm-40 -56.92 126.49 72.69 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.858 0.829 . . . . 0.0 113.174 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.614 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 46.6 Cg_exo -57.92 164.4 8.09 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.008 2.472 . . . . 0.0 113.035 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 31' ' ' ASP . 35.0 m -88.16 -6.85 57.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.66 109.44 19.68 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.42 -58.54 0.58 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' CA ' ' H ' ' A' ' 17' ' ' TRP . 38.6 m-80 53.21 127.55 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.195 . . . . 0.0 113.276 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.8 40.1 0.86 Allowed 'Cis proline' 0 C--N 1.374 1.905 0 CA-C-N 119.384 0.816 . . . . 0.0 112.857 -0.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' GLU . 73.9 m95 -82.14 12.84 3.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.41 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -78.41 -156.0 8.79 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.573 -0.285 . . . . 0.0 113.267 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -89.43 140.3 29.65 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.676 0.28 . . . . 0.0 110.32 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.3 m -52.26 157.12 2.45 Favored Pre-proline 0 N--CA 1.478 0.953 0 O-C-N 123.844 0.715 . . . . 0.0 112.413 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.41 146.39 32.92 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.949 2.433 . . . . 0.0 113.957 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.61 34.18 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.6 m -131.16 149.75 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.592 0.357 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -108.6 150.61 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.439 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.62 148.75 21.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.932 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 28' ' ' GLN . 48.1 mm -102.89 -64.44 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.333 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.447 ' HD1' ' O ' ' A' ' 30' ' ' THR . 9.7 t90 55.76 24.45 7.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.76 0.824 . . . . 0.0 112.82 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.603 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.8 mt-30 -98.29 11.44 37.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.832 0.825 . . . . 0.0 109.648 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.67 -51.45 0.12 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.706 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -146.49 -60.21 0.3 Allowed 'General case' 0 C--N 1.344 0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 12' ' ' CYS . 3.3 p30 159.49 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.891 1.277 . . . . 0.0 109.697 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.92 127.61 32.75 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.203 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.87 129.72 45.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.497 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.61 155.34 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 -144.79 16.76 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.72 86.26 1.99 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.259 0.552 . . . . 0.0 110.383 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' OXT' ' HB3' ' A' ' 7' ' ' PRO . 25.4 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.764 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.15 85.07 0.11 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.382 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -142.7 88.46 2.06 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.307 0.575 . . . . 0.0 110.124 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 7.8 p -93.49 154.31 17.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.51 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.3 m -150.71 156.59 36.2 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.177 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 114.16 1.8 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.339 2.026 . . . . 0.0 111.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD23 ' OXT' ' A' ' 37' ' ' CYS . 4.4 mm? 58.87 59.21 2.91 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.866 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.28 -70.64 0.02 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.939 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.57 151.85 77.65 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.904 0.352 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 6.9 Cg_exo -74.08 177.9 7.61 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.826 2.351 . . . . 0.0 112.884 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.8 t -99.33 -41.81 7.28 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.68 123.94 40.52 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.87 0.35 Allowed Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 m120 56.42 125.62 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.408 1.083 . . . . 0.0 112.784 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.15 26.08 2.55 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.298 0.785 . . . . 0.0 113.44 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -84.87 45.22 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.248 0.546 . . . . 0.0 111.538 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.49 170.77 24.67 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.795 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 p -91.6 146.99 23.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 5' ' ' CYS . 10.6 m -61.66 156.1 56.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.035 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.24 137.04 63.62 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.318 2.679 . . . . 0.0 113.656 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.74 -25.48 8.0 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.525 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -99.66 144.95 28.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.69 0.396 . . . . 0.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -103.73 157.62 5.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 123.368 0.417 . . . . 0.0 110.846 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -87.23 135.65 33.23 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.038 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 28' ' ' GLN . 46.8 mm -99.52 -73.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 t90 56.99 22.94 7.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.615 0.766 . . . . 0.0 112.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' H ' HG22 ' A' ' 26' ' ' ILE . 47.7 mt-30 -97.29 9.65 41.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.921 0.867 . . . . 0.0 109.746 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.58 -49.77 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.76 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.11 -64.03 0.28 Allowed 'General case' 0 C--N 1.345 0.388 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 11' ' ' PRO . 1.9 p30 160.6 45.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.809 1.244 . . . . 0.0 109.787 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -87.94 147.98 24.8 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.951 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 8' ' ' LEU . 62.3 m -105.16 116.72 32.43 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.765 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 35' ' ' GLY . 2.2 t -130.05 179.1 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.652 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 145.99 -115.79 0.84 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.661 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.23 31.12 4.14 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' OXT' HD23 ' A' ' 8' ' ' LEU . 25.6 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.927 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.34 -95.44 0.12 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -145.56 91.71 2.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.564 0.697 . . . . 0.0 110.468 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 19.7 p -119.83 171.59 8.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.9 m -152.77 157.21 33.35 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.9 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.724 1.616 . . . . 0.0 110.016 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 90.14 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.793 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 11' ' ' PRO . . . -174.2 -74.46 0.05 OUTLIER Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.426 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -78.73 109.11 9.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 117.451 0.625 . . . . 0.0 111.769 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 24.5 Cg_exo -64.89 179.33 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.003 2.469 . . . . 0.0 113.095 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.3 m -89.44 -16.27 31.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.012 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.07 112.72 24.34 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.394 0.434 . . . . 0.0 110.947 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.54 -76.66 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.302 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.767 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -91.56 -40.32 0.38 Allowed Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.33 145.88 41.0 Favored 'Cis proline' 0 C--N 1.372 1.777 0 CA-C-N 119.881 0.993 . . . . 0.0 113.151 -0.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 98.6 m95 -92.56 -49.58 6.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 97.72 158.32 30.5 Favored Glycine 0 C--N 1.338 0.676 0 O-C-N 123.447 0.467 . . . . 0.0 113.355 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 141.29 32.97 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -59.87 156.59 34.72 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 122.916 0.486 . . . . 0.0 112.246 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.51 141.26 20.07 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.638 2.892 . . . . 0.0 113.799 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.09 -30.04 11.23 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.141 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 m -101.81 136.02 42.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.667 0.387 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -119.05 158.47 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 123.479 0.487 . . . . 0.0 110.795 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.53 138.65 42.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.97 -54.94 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.1 t90 57.24 25.16 10.73 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.023 0.929 . . . . 0.0 112.731 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.19 11.31 38.23 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.721 0.772 . . . . 0.0 109.426 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.55 -51.76 0.19 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.233 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -146.62 -51.95 0.22 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 30' ' ' THR . 2.9 t70 137.84 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.563 . . . . 0.0 108.939 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.08 148.28 24.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.743 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.82 119.37 33.29 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.005 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -133.61 171.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.359 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 148.79 -119.79 1.11 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.081 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -133.18 28.44 4.1 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.627 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.999 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.478 0.18 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.96 -86.53 1.9 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.402 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.08 89.65 2.19 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 110.596 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 24.4 p 51.26 166.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.158 1.383 . . . . 0.0 113.914 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -153.82 156.93 32.53 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.93 105.0 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 121.942 1.761 . . . . 0.0 110.207 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD13 ' OXT' ' A' ' 37' ' ' CYS . 0.6 OUTLIER 57.5 86.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.078 -176.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.48 -74.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.992 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.22 124.62 89.35 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.236 0.518 . . . . 0.0 111.925 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 50.4 Cg_exo -55.4 161.12 7.74 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.955 2.437 . . . . 0.0 113.486 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.68 5.84 49.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.984 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.5 15.34 8.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.445 0.641 . . . . 0.0 112.311 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 17' ' ' TRP . . . 82.53 41.85 8.81 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.059 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -128.88 98.04 25.38 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 123.471 0.16 . . . . 0.0 111.17 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.72 -22.82 13.24 Favored 'Cis proline' 0 C--N 1.374 1.874 0 C-N-CA 125.259 -0.725 . . . . 0.0 113.027 -0.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 97.2 m95 -141.91 -36.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.279 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . 158.04 -162.42 32.19 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 123.506 0.504 . . . . 0.0 112.942 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 139.43 36.82 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.573 0.349 . . . . 0.0 110.142 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 m -61.1 156.88 46.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.32 139.66 35.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.505 2.803 . . . . 0.0 113.772 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.09 -29.2 8.18 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.213 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.4 m -99.2 136.44 39.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.736 0.415 . . . . 0.0 110.772 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.3 pp -99.56 156.52 3.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 O-C-N 123.344 0.403 . . . . 0.0 110.69 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.3 m -104.63 140.4 38.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.609 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -113.46 -67.59 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.944 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t90 58.65 29.75 18.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.195 0.998 . . . . 0.0 112.179 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -91.35 14.36 14.79 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.408 0.623 . . . . 0.0 110.693 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.35 -45.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.458 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -140.72 -48.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 10.3 t70 114.97 61.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.695 1.598 . . . . 0.0 108.911 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -99.41 154.07 18.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.3 m -86.66 123.97 32.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.65 165.46 28.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.649 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.04 -123.94 2.23 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -130.12 28.98 4.97 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.06 0.457 . . . . 0.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.401 ' OXT' HD13 ' A' ' 8' ' ' LEU . 21.0 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.962 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.558 0.218 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.61 57.93 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -150.28 95.73 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.537 0.684 . . . . 0.0 110.436 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.3 p -85.8 153.95 21.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.546 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -127.49 156.92 74.44 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.66 101.08 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 121.787 1.658 . . . . 0.0 110.46 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER 59.62 90.24 0.06 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.592 -176.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 -73.75 0.05 OUTLIER Glycine 0 CA--C 1.521 0.424 0 CA-C-N 114.978 -1.01 . . . . 0.0 114.152 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.83 144.84 44.86 Favored Pre-proline 0 N--CA 1.483 1.224 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 5.4 Cg_exo -78.79 150.31 23.9 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.869 2.379 . . . . 0.0 112.505 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.517 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 30.3 m -90.86 15.3 11.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.56 119.27 22.28 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.623 0.249 . . . . 0.0 111.268 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.03 -67.95 0.24 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.538 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.766 ' N ' ' HA ' ' A' ' 16' ' ' PRO . 2.8 t30 -93.02 -39.91 0.34 Allowed Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.1 Cg_endo -85.61 143.82 34.99 Favored 'Cis proline' 0 C--N 1.371 1.724 0 CA-C-N 119.889 0.996 . . . . 0.0 113.597 0.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -129.6 80.45 1.96 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -79.23 -153.09 7.31 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.194 -0.912 . . . . 0.0 114.231 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -73.86 142.42 46.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.674 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.8 m -51.75 156.64 2.28 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.63 128.99 22.44 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.396 2.731 . . . . 0.0 113.598 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.96 -25.08 3.96 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.165 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.93 152.05 38.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.641 0.377 . . . . 0.0 110.244 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -107.95 158.2 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.38 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -99.94 140.56 33.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.095 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' ARG . 28.5 mm -99.6 -64.39 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.984 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.423 ' HD1' ' O ' ' A' ' 30' ' ' THR . 11.0 t90 60.36 23.58 13.1 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.749 0.82 . . . . 0.0 112.514 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.75 10.26 40.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.817 0.818 . . . . 0.0 109.693 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.38 -52.56 0.18 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.853 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' HD1' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -148.04 -56.81 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.22 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER 156.01 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.465 1.506 . . . . 0.0 109.148 -178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 26' ' ' ILE . 59.7 mtp180 -81.12 140.17 35.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 92.9 m -100.85 129.99 46.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.697 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 35' ' ' GLY . 1.4 t -133.22 172.19 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.528 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 135.08 -130.25 5.39 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.384 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.14 81.65 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.287 0.565 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 8' ' ' LEU . 5.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.878 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.539 0.209 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.19 110.33 3.07 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.536 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 23.8 mt-10 -144.14 91.33 2.2 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.596 0.712 . . . . 0.0 110.626 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 14.2 p -140.7 167.17 22.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.1 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 t -142.77 151.46 56.81 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.899 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 52.7 Cg_exo -54.12 99.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 121.79 1.66 . . . . 0.0 110.21 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.32 95.77 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.108 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.64 -75.61 0.06 OUTLIER Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.298 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -61.06 142.1 93.26 Favored Pre-proline 0 C--N 1.356 0.885 0 CA-C-N 117.88 0.84 . . . . 0.0 112.711 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.615 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -65.23 163.62 28.48 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.996 2.464 . . . . 0.0 113.357 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 47.4 t -91.39 -9.26 45.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.23 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.543 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . . . -93.78 111.98 23.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.34 -64.57 0.38 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.074 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.23 121.83 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 124.406 1.083 . . . . 0.0 112.257 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.95 29.18 2.54 Favored 'Cis proline' 0 C--N 1.373 1.821 0 CA-C-N 119.351 0.804 . . . . 0.0 113.138 -0.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -85.4 32.43 0.56 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -92.21 -153.58 30.06 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.61 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.93 140.9 30.02 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.9 m -51.13 154.14 2.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.562 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.69 149.16 14.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.572 2.848 . . . . 0.0 113.947 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.04 7.3 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.446 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 26.6 m -102.34 155.52 18.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.575 0.35 . . . . 0.0 111.097 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -108.2 158.71 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -95.97 138.7 33.22 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.351 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 28' ' ' GLN . 40.7 mm -98.97 -74.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.015 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.0 t90 57.31 22.65 7.98 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.796 0.838 . . . . 0.0 112.599 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.562 ' H ' HG22 ' A' ' 26' ' ' ILE . 48.2 mt-30 -98.1 11.45 37.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.897 0.856 . . . . 0.0 109.719 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tt -149.77 -50.43 0.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 -61.65 0.33 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER 161.32 31.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.17 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.53 144.12 42.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.911 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 32.6 t -113.39 127.3 56.08 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.554 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER -127.12 169.37 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 134.24 -142.43 13.9 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.374 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -138.65 84.79 2.04 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 26.3 p . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.852 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.533 0.206 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.06 88.92 0.12 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 28.96 8.09 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.069 0.461 . . . . 0.0 111.515 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 25.6 p -93.15 160.21 14.95 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.382 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -136.06 157.76 75.14 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.891 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.38 100.27 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.852 1.701 . . . . 0.0 109.944 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.05 88.11 0.06 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.481 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.84 -76.21 0.03 OUTLIER Glycine 0 C--N 1.33 0.197 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.306 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.75 120.4 68.39 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 117.571 0.685 . . . . 0.0 112.113 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 61.8 Cg_exo -53.81 169.51 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.22 2.613 . . . . 0.0 113.557 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.4 t -87.93 -19.42 27.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -94.18 123.35 37.51 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.202 0.314 . . . . 0.0 111.347 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.36 -60.62 0.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.615 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 17' ' ' TRP . 8.8 p30 46.07 114.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 124.982 1.313 . . . . 0.0 113.684 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.66 74.57 0.13 OUTLIER 'Cis proline' 0 C--N 1.374 1.887 0 CA-C-N 119.505 0.859 . . . . 0.0 112.994 -0.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' ASN . 61.9 m95 -129.89 25.98 5.27 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.958 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 11' ' ' PRO . . . -81.66 178.91 53.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.842 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 p -88.83 146.79 24.76 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.571 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -53.72 152.87 8.92 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.267 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.65 138.59 67.48 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.347 2.698 . . . . 0.0 113.812 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.16 -6.32 12.0 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.943 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.6 m -127.57 145.59 50.81 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.427 0.291 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -103.46 158.64 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.992 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.0 m -98.53 129.79 45.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.351 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -98.82 -67.92 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.937 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.4 t90 61.15 22.42 12.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.052 0.941 . . . . 0.0 112.161 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.24 12.74 29.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.753 0.787 . . . . 0.0 109.75 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.38 -50.38 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -145.81 -53.82 0.27 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 30' ' ' THR . 5.5 t70 137.91 42.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.37 1.468 . . . . 0.0 109.246 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -91.41 153.57 19.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.464 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.1 m -99.78 122.17 42.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.866 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.69 144.52 29.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.091 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.51 -137.85 7.79 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -138.44 85.17 2.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.278 0.561 . . . . 0.0 110.58 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.865 179.713 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.38 89.88 0.11 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.561 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -134.63 82.55 1.97 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.352 0.596 . . . . 0.0 110.114 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.61 173.12 12.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.272 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -156.57 152.34 22.57 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.84 107.24 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.871 1.714 . . . . 0.0 111.341 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 33' ' ' CYS . 1.4 mm? 53.56 56.31 7.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.448 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 -71.24 0.12 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.783 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.29 153.14 59.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.326 0.563 . . . . 0.0 111.803 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.43 166.43 27.47 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.86 2.373 . . . . 0.0 112.768 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' TRP . 25.3 p -109.01 -15.11 14.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.984 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.23 111.56 23.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.96 0.41 . . . . 0.0 111.653 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.38 76.5 1.24 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.687 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.99 ' H ' ' HA ' ' A' ' 16' ' ' PRO . 41.8 m-80 -146.94 -45.01 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.909 -0.567 . . . . 0.0 112.167 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.99 ' HA ' ' H ' ' A' ' 15' ' ' ASN . 1.2 Cg_endo -84.87 127.13 10.79 Favored 'Cis proline' 0 C--N 1.373 1.835 0 CA-C-N 120.002 1.037 . . . . 0.0 112.858 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.568 ' N ' ' HB2' ' A' ' 15' ' ' ASN . 3.3 m95 61.91 100.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.684 0.794 . . . . 0.0 111.346 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.75 36.64 2.93 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.949 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 t -116.65 133.25 56.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -57.02 149.62 44.07 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.08 131.46 44.85 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.391 2.727 . . . . 0.0 113.923 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 98.51 24.06 11.58 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.443 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -127.31 127.49 44.39 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.514 0.326 . . . . 0.0 111.303 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.1 pt -101.65 162.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.399 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -126.61 149.54 49.41 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 111.952 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -99.5 -60.97 2.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 178.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 31' ' ' ASP . 11.5 t90 56.81 86.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.497 1.119 . . . . 0.0 112.395 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -130.55 8.47 4.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.43 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -177.35 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.492 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -44.96 0.47 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 9.0 t70 94.44 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.702 1.201 . . . . 0.0 109.387 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.84 148.61 22.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.559 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' HD12 ' A' ' 8' ' ' LEU . 36.4 m -86.24 125.9 33.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.807 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -122.86 144.61 31.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.379 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.08 -141.63 13.22 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 123.518 0.512 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -146.96 90.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB3' ' C ' ' A' ' 22' ' ' GLY . 25.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.004 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.509 0.195 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.24 95.64 0.68 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -144.7 91.63 2.19 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.444 0.64 . . . . 0.0 110.568 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.3 p 50.81 173.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.058 1.343 . . . . 0.0 113.817 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -156.26 156.13 29.86 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.43 100.07 0.15 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.727 1.618 . . . . 0.0 109.666 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 60.33 91.08 0.06 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.422 -175.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.7 -77.15 0.05 OUTLIER Glycine 0 CA--C 1.516 0.148 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.307 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.32 149.17 78.66 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 117.454 0.627 . . . . 0.0 111.78 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 3.5 Cg_exo -77.71 169.64 20.47 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.693 2.262 . . . . 0.0 112.413 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.96 -19.18 30.81 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.322 0.389 . . . . 0.0 112.011 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.22 119.77 35.31 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.31 0.381 . . . . 0.0 110.999 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -58.35 0.42 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.566 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 48.19 127.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 125.219 1.408 . . . . 0.0 113.61 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.1 19.26 5.49 Favored 'Cis proline' 0 C--N 1.373 1.821 0 C-N-CA 125.229 -0.738 . . . . 0.0 113.575 0.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -90.67 61.35 4.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.492 0.663 . . . . 0.0 110.83 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -98.0 -148.91 24.41 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.718 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.2 m -115.58 135.51 54.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.92 0.423 . . . . 0.0 110.058 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -68.06 158.14 84.88 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.705 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.41 137.96 39.05 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.186 2.591 . . . . 0.0 114.231 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.64 11.31 57.05 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.824 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 m -124.66 152.61 43.44 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.622 0.369 . . . . 0.0 111.186 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 34' ' ' VAL . 1.9 pp -129.29 160.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.712 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.6 m -131.77 148.52 52.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.37 -66.81 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.298 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 11.9 t90 63.82 27.77 14.62 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.945 0.898 . . . . 0.0 111.794 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -92.3 12.59 21.98 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.518 0.675 . . . . 0.0 110.21 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.92 -45.98 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.399 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.661 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.7 OUTLIER -135.93 -61.48 0.71 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 30' ' ' THR . 7.4 t70 132.74 59.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.455 1.502 . . . . 0.0 109.093 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -91.97 140.3 29.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.1 t -94.36 117.51 30.23 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.662 0.601 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -130.15 173.12 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.733 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 147.93 -142.32 10.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.834 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -131.22 26.94 4.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.088 0.471 . . . . 0.0 111.317 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.942 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.52 0.2 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.41 104.21 2.56 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -148.84 94.36 2.25 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.581 0.705 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 26.0 p -93.17 169.22 10.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.566 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 t -149.47 152.02 34.55 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.213 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 53.1 Cg_exo -54.59 101.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 121.889 1.726 . . . . 0.0 110.285 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.16 93.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.592 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.52 -74.88 0.06 OUTLIER Glycine 0 C--N 1.332 0.35 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.42 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.12 125.73 91.97 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 117.548 0.674 . . . . 0.0 111.212 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 76.5 Cg_exo -51.85 160.4 2.95 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.196 2.597 . . . . 0.0 113.398 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.16 -18.05 26.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.649 0.593 . . . . 0.0 112.553 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.76 123.89 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.694 0.283 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.16 -57.76 0.48 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.99 122.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 125.123 1.369 . . . . 0.0 113.572 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.97 16.29 6.17 Favored 'Cis proline' 0 C--N 1.374 1.87 0 CA-C-N 119.09 0.711 . . . . 0.0 113.674 0.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -84.74 57.66 4.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.475 0.655 . . . . 0.0 111.135 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . -111.86 -172.76 19.23 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.891 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 p -92.41 143.29 26.53 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.801 0.353 . . . . 0.0 110.076 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.1 m -52.4 156.3 3.07 Favored Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 123.689 0.618 . . . . 0.0 112.4 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.06 148.02 50.45 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.889 2.393 . . . . 0.0 113.754 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' C ' ' HB3' ' A' ' 37' ' ' CYS . . . 108.94 -30.38 8.75 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.758 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.4 m -98.66 153.06 18.98 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.546 0.338 . . . . 0.0 111.198 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.1 pp -108.88 163.64 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -107.6 133.19 52.41 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.991 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -95.27 -68.86 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 123.361 0.413 . . . . 0.0 111.369 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 4.3 t90 61.87 20.65 11.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -96.05 11.28 34.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.887 0.851 . . . . 0.0 109.669 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.2 mt -148.16 -50.43 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.054 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -61.02 0.3 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 11' ' ' PRO . 3.5 p30 154.96 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.038 -178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 26' ' ' ILE . 99.7 mtt180 -81.23 156.6 25.54 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 5.8 t -115.71 116.4 28.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.166 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -118.63 169.05 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.2 -143.28 14.55 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -139.28 85.94 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.263 0.554 . . . . 0.0 110.152 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB3' ' N ' ' A' ' 23' ' ' CYS . 26.8 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.859 179.683 . . . . . . . . 1 1 . 1 stop_ save_